|Day Low/High||16.74 / 16.81|
|52 Wk Low/High||11.08 / 17.88|
Vast majority of adults are not getting enough of two nutrients crucial for vision
Royal DSM's stock was hit by a strengthening Euro earlier this year, but the shares have done well as the company has transformed itself in the past year, says the company's CEO Feike Sijbesma.
Materials sales in Europe remain slow, and China is decoupling from the U.S., says Stephen Tanda, Managing Board Director at Royal DSM.